Annual CFI
-$2.93 M
+$16.06 M+84.57%
December 31, 2023
Summary
- As of February 25, 2025, BCYC annual cash flow from investing activities is -$2.93 million, with the most recent change of +$16.06 million (+84.57%) on December 31, 2023.
- During the last 3 years, BCYC annual CFI has fallen by -$1.73 million (-144.08%).
- BCYC annual CFI is now -163.16% below its all-time high of -$1.11 million, reached on December 31, 2017.
Performance
BCYC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$435.00 K
-$15.00 K-3.57%
September 30, 2024
Summary
- As of February 25, 2025, BCYC quarterly cash flow from investing activities is -$435.00 thousand, with the most recent change of -$15.00 thousand (-3.57%) on September 30, 2024.
- Over the past year, BCYC quarterly CFI has dropped by -$15.00 thousand (-3.57%).
- BCYC quarterly CFI is now -3525.00% below its all-time high of -$12.00 thousand, reached on March 31, 2024.
Performance
BCYC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$918.00 K
+$67.00 K+6.80%
September 30, 2024
Summary
- As of February 25, 2025, BCYC TTM cash flow from investing activities is -$918.00 thousand, with the most recent change of +$67.00 thousand (+6.80%) on September 30, 2024.
- Over the past year, BCYC TTM CFI has increased by +$67.00 thousand (+6.80%).
- BCYC TTM CFI is now -247.73% below its all-time high of -$264.00 thousand, reached on March 31, 2018.
Performance
BCYC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BCYC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +84.6% | -3.6% | +6.8% |
| 3 y3 years | -144.1% | -3.6% | +6.8% |
| 5 y5 years | -147.0% | -3.6% | +6.8% |
BCYC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.3% | +84.6% | -3525.0% | +95.6% | -9.0% | +95.2% |
| 5 y | 5-year | -144.1% | +84.6% | -3525.0% | +95.6% | -9.0% | +95.2% |
| alltime | all time | -163.2% | +84.6% | -3525.0% | +95.6% | -247.7% | +95.2% |
Bicycle Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$435.00 K(+3.6%) | -$918.00 K(-6.8%) |
| Jun 2024 | - | -$420.00 K(+3400.0%) | -$985.00 K(+17.0%) |
| Mar 2024 | - | -$12.00 K(-76.5%) | -$842.00 K(-71.3%) |
| Dec 2023 | -$2.93 M(-84.6%) | -$51.00 K(-89.8%) | -$2.93 M(-32.3%) |
| Sep 2023 | - | -$502.00 K(+81.2%) | -$4.33 M(-36.5%) |
| Jun 2023 | - | -$277.00 K(-86.8%) | -$6.81 M(-58.3%) |
| Mar 2023 | - | -$2.10 M(+45.0%) | -$16.33 M(-14.0%) |
| Dec 2022 | -$18.99 M(+835.3%) | -$1.45 M(-51.5%) | -$18.99 M(+2.0%) |
| Sep 2022 | - | -$2.98 M(-69.5%) | -$18.61 M(+17.8%) |
| Jun 2022 | - | -$9.80 M(+106.0%) | -$15.79 M(+156.2%) |
| Mar 2022 | - | -$4.76 M(+345.7%) | -$6.16 M(+203.6%) |
| Dec 2021 | -$2.03 M | -$1.07 M(+531.4%) | -$2.03 M(+40.3%) |
| Sep 2021 | - | -$169.00 K(-1.2%) | -$1.45 M(+5.4%) |
| Jun 2021 | - | -$171.00 K(-72.6%) | -$1.37 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$623.00 K(+28.7%) | -$1.50 M(+25.3%) |
| Dec 2020 | -$1.20 M(-22.8%) | -$484.00 K(+409.5%) | -$1.20 M(+8.4%) |
| Sep 2020 | - | -$95.00 K(-68.4%) | -$1.11 M(-14.5%) |
| Jun 2020 | - | -$301.00 K(-5.9%) | -$1.29 M(-11.1%) |
| Mar 2020 | - | -$320.00 K(-18.2%) | -$1.46 M(-6.3%) |
| Dec 2019 | -$1.55 M(+31.1%) | -$391.00 K(+38.2%) | -$1.55 M(-1.2%) |
| Sep 2019 | - | -$283.00 K(-38.9%) | -$1.57 M(+11.1%) |
| Jun 2019 | - | -$463.00 K(+10.8%) | -$1.42 M(+5.7%) |
| Mar 2019 | - | -$418.00 K(+2.0%) | -$1.34 M(+13.0%) |
| Dec 2018 | -$1.19 M(+6.6%) | -$410.00 K(+225.4%) | -$1.19 M(+52.8%) |
| Sep 2018 | - | -$126.00 K(-67.4%) | -$776.00 K(+19.4%) |
| Jun 2018 | - | -$386.00 K(+46.2%) | -$650.00 K(+146.2%) |
| Mar 2018 | - | -$264.00 K | -$264.00 K |
| Dec 2017 | -$1.11 M | - | - |
FAQ
- What is Bicycle Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual CFI year-on-year change?
- What is Bicycle Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly CFI year-on-year change?
- What is Bicycle Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bicycle Therapeutics?
- What is Bicycle Therapeutics TTM CFI year-on-year change?
What is Bicycle Therapeutics annual cash flow from investing activities?
The current annual CFI of BCYC is -$2.93 M
What is the all time high annual CFI for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual cash flow from investing activities is -$1.11 M
What is Bicycle Therapeutics annual CFI year-on-year change?
Over the past year, BCYC annual cash flow from investing activities has changed by +$16.06 M (+84.57%)
What is Bicycle Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BCYC is -$435.00 K
What is the all time high quarterly CFI for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly cash flow from investing activities is -$12.00 K
What is Bicycle Therapeutics quarterly CFI year-on-year change?
Over the past year, BCYC quarterly cash flow from investing activities has changed by -$15.00 K (-3.57%)
What is Bicycle Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BCYC is -$918.00 K
What is the all time high TTM CFI for Bicycle Therapeutics?
Bicycle Therapeutics all-time high TTM cash flow from investing activities is -$264.00 K
What is Bicycle Therapeutics TTM CFI year-on-year change?
Over the past year, BCYC TTM cash flow from investing activities has changed by +$67.00 K (+6.80%)